Patents Assigned to GelTex Pharmaceuticals, Inc. Waltham, MA
  • Publication number: 20030049226
    Abstract: The invention relates to a method for treating Syndrome X, or inhibiting the onset of symptoms of Syndrome X in a patient, and includes administering a therapeutically effective amount of a salt of at least one alkylated and cross-linked polymer, or a copolymer thereof, the polymer salt formed as a product of the reaction of one or more polymers, or salts and copolymers thereof, having a repeat unit that is essentially: 1
    Type: Application
    Filed: April 17, 2002
    Publication date: March 13, 2003
    Applicant: GelTex Pharmaceuticals, Inc. Waltham, MA
    Inventors: Steven K. Burke, Joanne M. Donovan